※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
  
        
11:10-12:10
        
        
                
                        
                            - Plenary Lecture 1: 
- Past and Future Treatment of HER2-positive Breast Cancer  
- Venue:  
- Halla Hall
 
           
                  
                    
                    
- Can Anti-HER2 Treatment for Advanced Breast Cancer Disease Be Individualized in 2017?
 
- Martine Piccart (Institut Jules Bordet, Belgium)Slide ViewVideo ViewAbstract
 
         
   
    
12:10-13:10
        
        
                
                        
                            - Satellite Symposium 1
-   
- Venue:  
- Halla Hall
 
           
                  
                    
                    
- The Role of Faslodex in Advanced Breast Cancer Management Pursuing Long Term Treatment Strategy
 
- Peter Schmid (Barts Cancer Institute, Queen Mary Univ. of London, United Kingdom)
 
         
   
    
13:30-14:30
        
        
                
                        
                            - Plenary Lecture 2
-   
- Venue:  
- Halla Hall
 
           
                  
                    
                    
- What Is the Current Concept of Molecular Portraits of Human Breast Tumors
 
- Katherine A. Hoadley (On behalf of Prof. Charles M. Perou) (Univ. of North Carolina at Chapel Hill, U.S.A.)Slide ViewVideo ViewAbstract
 
         
   
    
14:40-15:50
        
        
                
                        
                            - Symposium 1: 
- Breast Cancer Prevention and Screening  
- Venue:  
- Halla Hall
 
           
                  
                    
                    
- Breast Cancer Screening: Harm or Good?
 
- Steven A Narod (Women's College Research Institute, Women's College Hospital, Dalla Lana School of Public Health, Univ. of Toronto, Canada)Slide ViewVideo ViewAbstract
- Assessment of Breast Cancer Risk with Genetic Polymorphisms
 
- Antonis Antoniou (Univ. of Cambridge, United Kingdom)Slide ViewVideo ViewAbstract
- Germline Testing for Hereditary Cancer with Multigene Panel
 
- Po-Han Lin (National Taiwan Univ. Hospital, Taiwan)Slide ViewVideo ViewAbstract	
	
 
         
   
    
        
        
                
                        
                            - Panel Discussion 1: 
- Elderly Breast Cancer  
- Venue:  
- Lotus Hall
 
           
                  
         
   
    
        
        
                
                        
                            - Oral Presentation 1
-   
- Venue:  
- Weolla Room
 
           
                  
                    
                    
- POTENTIAL APPLICATION OF GUGGULSTERONE AS A NOVEL ANTAGONIST OF CXCR4 EXPRESSION IN TRIPLE-NEGATIVE BREAST CANCER
 
- Gautam Sethi (National Univ. of Singapore, Singapore)Abstract
- A RADIOSENSITIVITY GENE SIGNATURE AND PD-L1 STATUS PREDICT CLINICAL OUTCOME OF PATIENTS WITH INVASIVE BREAST CARCINOMA IN THE CANCER GENOME ATLAS (TCGA) DATASET
 
- Bum-Sup Jang (Seoul National Univ. Hospital, Korea)Slide ViewAbstract
- INTERPLAY BETWEEN MEVALONATE AND HIPPO PATHWAYS REGULATES DDX20 VIA YAP IN INVASIVE BREAST CANCERS
 
- Chao Wang (National Univ. of Singapore, Singapore)Slide ViewAbstract	
	
- CO-EXISTENCE OF DUCTAL CARCINOMA WITHIN PHYLLODES TUMOR - A REVIEW OF 557 PHYLLODES TUMORS FROM A TWENTY-YEAR REGION-WIDE DATABASE IN HONG KONG AND SHENZHEN, CHINA
 
- Michael Co (The Univ. of Hong Kong, Hong Kong)Slide ViewAbstract	
- RANDOMIZED PHASE III TRIAL OF IRINOTECAN COMBINED WITH CAPECITABINE VERSUS CAPECITABINE IN PATIENTS WITH METASTATIC BREAST CANCER (MBC) PREVIOUSLY TREATED WITH ANTHRACYCLINE AND TAXANES PROCEED TRIAL
 
- In Hae Park (National Cancer Center, Korea)Slide ViewAbstract
- DETECTION OF SPLICEOMIC SIGNATURES FOR PREDICTING ENDOCRINE RESISTANCE IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
 
- Han-Byoel Lee (Seoul National Univ. Hospital, Korea)Slide ViewAbstract
- INHERITED MUTATIONS IN BRCA1 AND BRCA2 IN AN UNSELECTED MULTI-ETHNIC COHORT OF ASIAN BREAST CANCER PATIENTS AND HEALTHY CONTROLS FROM MALAYSIA
 
- Min Min Tan (Cancer Research Malaysia, Malaysia)Slide ViewAbstract
- CLINICAL APPLICATION OF MULTIGENE PANEL TESTING AND GENETIC COUSELING FOR HEREDITARY/FAMILIAL BREAST CANCER RISK ASSESSMENT: PROSPECTIVE SINGLE CENTER STUDY
 
- Eun-Shin Lee (Seoul National Univ. College of Medicine, Korea)Slide ViewAbstract
 
         
   
    
16:00-17:10
        
        
                
                        
                            - Education Session 1: 
- New Issues in Cancer Research and Treatment  
- Venue:  
- Halla Hall
 
           
                  
                    
                    
- Clinical Utility of Liquid Biopsy in Cancer
 
- Byung-Joo Chae (The Catholic Univ. of Korea, Seoul St. Mary’s Hospital, Korea)Slide ViewVideo ViewAbstract
- Actionable Genome Analysis for Human Cancer
 
- Woong-Yang Park (Samsung Medical Center, Korea)Slide ViewVideo ViewAbstract
- New Issues in Cancer Genomics for the Research and Treatment
 
- Tae-Min Kim (College of Medicine, The Catholic Univ. of Korea, Korea)Slide ViewVideo ViewAbstract	
	
 
         
   
    
        
        
                
                        
                            - Panel Discussion 2: 
- Special Issues in Stage IV Breast Cancer  
- Venue:  
- Lotus Hall
 
           
                  
                    
                    
- Surgery for Stage IV Breast Cancer: No Benefit at All?
 
- Jin Zhang (Tianjin Medical Univ. Cancer Center, China)Slide ViewVideo ViewAbstract
- New Therapeutic Strategy for CNS Metastases in Breast Cancer
 
- Hee Kyung Ahn (Gachon Univ. Gil Medical Center, Korea)Slide ViewVideo ViewAbstract
- How Long Should We Treat Patients with Metastatic Breast Cancer? Is Cure Possible?
 
- Louis Chow (Macau Univ. of Science and Technology, Hong Kong)Slide ViewVideo ViewAbstract